Effect of baseline geriatric and quality of life assessments on treatment outcomes in ECOG-ACRIN EA2186 (GIANT): A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer.

Authors: Efrat Dotan, Paul J. Catalano, Leon Lenchik, Robert Boutin, Xin Yao, James Ohr, Kian-Huat Lim, George A. Fisher, Namrata Vijayvergia, Sreenivasa R Chandana, Aparna Kalyan, Richard Francis Dunne, David Bing Zhen, Daneng Li, Kim Anna Reiss, Melissa A. Simon, Jordan Berlin, Lynne I. Wagner, Peter J. O'Dwyer

Published: 2025-01-27

DOI: 10.1200/jco.2025.43.4_suppl.676

Source: Full article

---

Abstract

676